Reach Us +44-3308187254


Levothyroxine Replacement In Management Of Ovarian Hyperstimulation Syndrome Associated With Hypothyroidism In Two Members Of A Family | 13276
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Levothyroxine replacement in management of ovarian hyperstimulation syndrome associated with hypothyroidism in two members of a family

International Summit on Clinical Pharmacy & Dispensing

F. Ghazanfari Amlashi, M.H Hedayati Emami and R.Molaei Langroudi

ScientificTracks Abstracts: Clinic Pharmacol Biopharmaceut

DOI: 10.4172/2167-065X.S1.002

Introduction: Ovarian hyperstimulation syndrome (OHSS) is usually iatrogenic and potentially life-threatening complication of ovulation induction. It can occur rarely following hypothyroidism. We report this syndrome in two members of a family with hypothyoidism and describe the effects of levothyroxine replacement in the management of it. Cases: A 15 years Old girl presented with abdominal pain and distention for a few months. On examination, she had classic features of hypothyroidism. Abdominal ultrasound revealed enlarged ovaries with multilobulated ovarian cysts (Right ovary: 150?75mm, volume: 454cc; Left ovary: 130?70 mm, volume: 340cc).The second patient, a 14.5 years old girl (the cousin of the patient1) presented to the emergency unit with acute abdominal pain, nausea and vomiting after a minor trauma. she had also classic features of hypothyroidism. Abdominal ultrasound revealed enlarged ovaries with multilobulated ovarian cysts(Right ovary: 110? 65 mm, volume: 279cc; Left ovary: 118? 58 mm, volume: 285cc). Both patients,started on levothyroxine 100 μg per day regarding their thyroid function test.hypothyroid features resolved and thyroid function test became normal after 2 months. Follow-up ultrasound of the first patient, showed significantly smaller ovaries after 6week and became normal with complete resolution of cysts after 4 months. The second patient who was less compliant with her treatment also showed improvement, but in longer duration. Conclusion: In OHSS associated with hypothyroidism, patients could benefit from levothyroxine replacemnet not only for treatment of hypothyroidism but also for achieving normalization of ovary size with regression of cysts within a few months.
Fatemeh.Ghazanfari Amlashi obtained her medical diploma at Guilan University of Medical Sciences in 2009; she delivered a unique thesis about the role of biomarkers in diffuse axonal injury and published it in a reputed journal. After graduation, she worked for 2 years in a rural clinic to improve her practical talents. Then, she has started collaboration with Guilan Endocrinology and Metabolic Research Center and presented one of their works in ICE/ECE 2012 as a poster. She has published one article in an omicsgroup-related journal. As a young general practitioner, she would like to pursue her studies as both medical researcher and specialist, particularly in the field of internal medicine.